AnalystsGeoff MeachamGeoff Meacham's Stock Forecasts
AnalystsGeoff Meacham
Analyst Ranking
Bottom 6%
#3401 out of 3583 analysts
Average Return
-2.86%
Win Rate
47%36 out of 76
Risk vs Reward
Poor
Good
Geoff Meacham's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Ii-Vi IncIIVI | +150.48% | $26.29 | $65.85 | 2020-03-22 - 2021-03-23 | Strong Buy |
Seagen IncSGEN | +85.57% | $55.30 | $102.62 | 2018-10-25 - 2019-10-25 | Strong Buy |
BioXcel Therapeutics IncBTAI | +83.38% | $20.52 | $37.63 | 2020-03-31 - 2021-04-01 | Strong Buy |
Neurocrine Biosciences IncNBIX | +59.15% | $72.78 | $115.83 | 2017-11-01 - 2018-11-02 | Strong Buy |
Acceleron Pharma IncXLRN | +54.97% | $37.73 | $58.47 | 2017-09-19 - 2018-09-20 | Strong Buy |
Geoff Meacham's Stock Coverage
| Name / Ticker | # of Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
CureVac NVCVAC | 3 | Sell | $20.00 | +8.81% | Downgrades | 6 days ago |
Acumen Pharmaceuticals IncABOS | 2 | Strong Buy | $14.00 | +175.05% | Upgrades | 6 days ago |
Inovio Pharmaceuticals IncINO | 2 | Hold | $10.00 | +147.52% | Upgrades | 6 days ago |
Moderna IncMRNA | 4 | Hold | $180.00 | +18.00% | Upgrades | 6 days ago |
Amgen IncAMGN | 5 | Hold | $255.00 | +13.31% | Downgrades | 22 days ago |
Regeneron Pharmaceuticals IncREGN | 3 | Sell | $575.00 | -4.67% | Downgrades | 22 days ago |
Pfizer IncPFE | 4 | Strong Buy | $70.00 | +33.23% | Upgrades | 22 days ago |
Kiniksa Pharmaceuticals LtdKNSA | 2 | Strong Buy | $34.00 | +211.93% | Maintains | a month ago |
Biogen IncBIIB | 5 | Hold | $275.00 | +23.70% | Maintains | a month ago |
Vaxxinity IncVAXX | 1 | Strong Buy | $21.00 | +169.58% | Initiates Coverage On | 2 months ago |
Tyra Biosciences IncTYRA | 1 | Strong Buy | $22.00 | +85.50% | Initiates Coverage On | 4 months ago |
Checkmate Pharmaceuticals IncCMPI | 1 | Strong Buy | $7.00 | +238.16% | Upgrades | 4 months ago |
BridgeBio Pharma IncBBIO | 2 | Strong Buy | $75.00 | +631.71% | Upgrades | 5 months ago |
Kymera Therapeutics IncKYMR | 2 | Strong Buy | $80.00 | +101.21% | Upgrades | 5 months ago |
Century Therapeutics IncIPSC | 1 | Strong Buy | $34.00 | +158.56% | Initiates Coverage On | 6 months ago |
Lyell Immunopharma IncLYEL | 1 | Strong Buy | $25.00 | +358.72% | Initiates Coverage On | 6 months ago |
Janux Therapeutics IncJANX | 1 | Strong Buy | $35.00 | +145.61% | Initiates Coverage On | 7 months ago |
Y-mAbs Therapeutics IncYMAB | 1 | Hold | $56.00 | N/A | Downgrades | a year ago |
Intercept Pharmaceuticals IncICPT | 2 | Sell | N/A | N/A | Downgrades | a year ago |
Esperion Therapeutics IncESPR | 2 | Hold | $35.00 | N/A | Downgrades | a year ago |
Seagen IncSGEN | 6 | Strong Buy | N/A | N/A | Upgrades | a year ago |
Galecto IncGLTO | 1 | Strong Buy | $21.00 | N/A | Initiates Coverage On | a year ago |
PMV Pharmaceuticals IncPMVP | 1 | Strong Buy | $42.00 | N/A | Initiates Coverage On | a year ago |
Omeros CorpOMER | 1 | Strong Buy | $21.00 | N/A | Initiates Coverage On | a year ago |
Vir Biotechnology IncVIR | 1 | Strong Buy | $55.00 | N/A | Initiates Coverage On | a year ago |
CRISPR Therapeutics AGCRSP | 1 | Strong Buy | $110.00 | N/A | Initiates Coverage On | a year ago |
MeiraGTx Holdings plcMGTX | 1 | Strong Buy | $20.00 | N/A | Reinstates | a year ago |
Sangamo Therapeutics IncSGMO | 1 | Strong Buy | $20.00 | N/A | Reinstates | a year ago |
Poseida Therapeutics IncPSTX | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | a year ago |
Royalty Pharma plcRPRX | 1 | Strong Buy | $55.00 | N/A | Initiates Coverage On | 2 years ago |
Puma Biotechnology IncPBYI | 1 | Sell | $9.00 | N/A | Reinstates | 2 years ago |
REGENXBIO IncRGNX | 1 | Strong Buy | $60.00 | N/A | Reinstates | 2 years ago |
Genfit SAGNFT | 1 | Sell | $7.00 | N/A | Initiates Coverage On | 2 years ago |
Eidos Therapeutics IncEIDX | 1 | Hold | $51.00 | N/A | Initiates Coverage On | 2 years ago |
BioXcel Therapeutics IncBTAI | 2 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 2 years ago |
Ii-Vi IncIIVI | 1 | Strong Buy | $31.00 | N/A | Initiates Coverage On | 2 years ago |
Alexion Pharmaceuticals IncALXN | 1 | Hold | $110.00 | N/A | Downgrades | 2 years ago |
UNITED THERAPEUTICS CorpUTHR | 2 | Strong Sell | $95.00 | N/A | Maintains | 3 years ago |
Myovant Sciences LtdMYOV | 2 | Strong Buy | $25.00 | N/A | Upgrades | 3 years ago |
DBV Technologies SADBVT | 2 | Hold | $8.00 | N/A | Downgrades | 3 years ago |
Ptc Therapeutics IncPTCT | 7 | Hold | $40.00 | N/A | Maintains | 3 years ago |
Gritstone bio IncGRTS | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 3 years ago |
Merck & Co IncMRK | 4 | Strong Buy | $78.00 | N/A | Maintains | 3 years ago |
ELI LILLY & CoLLY | 4 | Strong Buy | $120.00 | N/A | Maintains | 3 years ago |
Bristol Myers Squibb CoBMY | 3 | Hold | $58.00 | N/A | Maintains | 3 years ago |
Neurocrine Biosciences IncNBIX | 2 | Strong Buy | $135.00 | N/A | Maintains | 3 years ago |
Prothena Corp Public Ltd CoPRTA | 2 | Strong Sell | N/A | N/A | Downgrades | 4 years ago |
Zymeworks IncZYME | 2 | Hold | N/A | N/A | Upgrades | 4 years ago |
Ironwood Pharmaceuticals IncIRWD | 1 | Hold | $20.00 | N/A | Maintains | 4 years ago |
Gilead Sciences IncGILD | 3 | Strong Buy | $90.00 | N/A | Maintains | 4 years ago |
Incyte CorpINCY | 2 | Strong Buy | $135.00 | N/A | Maintains | 4 years ago |
AbbVie IncABBV | 2 | Hold | $102.00 | N/A | Maintains | 4 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Acceleron Pharma IncXLRN | 2 | Strong Buy | $54.00 | N/A | Maintains | 4 years ago |
Celgene CorpCELG | 4 | Strong Buy | N/A | N/A | Upgrades | 4 years ago |
Vertex Pharmaceuticals IncVRTX | 2 | Strong Buy | $200.00 | N/A | Maintains | 4 years ago |
Alnylam Pharmaceuticals IncALNY | 4 | Strong Buy | $158.00 | N/A | Maintains | 4 years ago |
Johnson & JohnsonJNJ | 1 | Hold | $148.00 | N/A | Maintains | 4 years ago |
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.